CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$3.36
-0.03 (-0.74%)
Open$3.34
Previous Close$3.38
Day High$3.41
Day Low$3.34
52W High$8.48
52W Low$1.03
Volume—
Avg Volume31.5K
Market Cap13.68M
P/E Ratio—
EPS$-1.37
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+548.9% upside
Current
$3.36
$3.36
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.64M | 2.44M | 1.11M |
| Net Income | -4,490,146 | -3,729,357 | -131,808 |
| Profit Margin | -170.1% | -161.6% | -11.8% |
| EBITDA | -4,652,894 | -4,079,226 | -161,572 |
| Free Cash Flow | — | — | -153,109 |
| Rev Growth | +8.4% | +8.4% | +14.6% |
| Debt/Equity | — | — | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.31 | +0.38% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $360.55 | +0.62% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.33 | -1.21% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $499.65 | +1.69% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $631.81 | -0.17% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.52 | +0.74% | 69.3 | 39.97B |